Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.61 USD | -6.30% | +1.67% | -25.76% |
13/05 | Tocagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
18/03 | Forte Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.76% | 23.69M | |
+8.38% | 115B | |
+10.13% | 105B | |
-11.69% | 22.71B | |
+2.21% | 21.83B | |
-10.88% | 18.18B | |
-41.90% | 16.52B | |
-16.00% | 16.01B | |
+2.28% | 14.14B | |
+20.54% | 10.71B |
- Stock Market
- Equities
- FBRX Stock
- News Forte Biosciences, Inc.
- Forte Biosciences : Chardan Adjusts Forte Biosciences' Price Target to $115 From $110, Keeps at Buy